Matinas BioPharma Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q2 2024 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q3 2024 | 1 | -$0.89 | -$0.89 | -$0.89 |
Matinas BioPharma Holdings, Inc. Earnings Date And Information
Matinas BioPharma Holdings, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-1 earnings per share for the quarter, missing analysts' consensus estimates of $-0.83333 by $0.16667. The company had revenue of 0 for the quarter and had revenue of 1.10 M for the year. Matinas BioPharma Holdings, Inc. has generated $-5 earnings per share over the last year ($-5.28 diluted earnings per share) and currently has a price-to-earnings ratio of -0.15. Matinas BioPharma Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based on prior year's report dates.
Matinas BioPharma Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.85 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.83 | -$1.15 | -0.32 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.03 | -$1.34 | -1.31 | $0 | |
| 03/27/2024 | Q4 2023 | -$0.02 | -$1.22 | -1.2 | $-1,096,000 | |
| 11/08/2023 | Q3 2023 | -$0.03 | -$1.39 | -1.36 | $300,000 | $0 |
| 08/09/2023 | Q2 2023 | -$0.03 | -$1.39 | -1.36 | $300,000 | $0 |
| 05/10/2023 | Q1 2023 | -$0.03 | -$1.25 | -1.22 | $1.10 M | |
| 03/15/2023 | Q4 2022 | -$0.02 | -$0.01 | 0.01 | $1.06 M | |
| 11/02/2022 | Q3 2022 | -$0.03 | -$1.26 | -1.23 | $1.13 M | $1.06 M |
| 08/11/2022 | Q2 2022 | -$0.03 | -$1.36 | -1.33 | $83,333 | $1.06 M |
| 05/12/2022 | Q1 2022 | -$0.03 | -$0.58 | -0.56 | $0 | |
| 03/08/2022 | Q4 2021 | -$0.03 | -$1.55 | -1.52 | $-33,300 | |
| 11/08/2021 | Q3 2021 | -$0.02 | -$1.59 | -1.57 | $2.03 M | $0 |
| 08/10/2021 | Q2 2021 | -$0.02 | -$1.17 | -1.16 | $25,000 | $0 |
| 05/10/2021 | Q1 2021 | -$0.03 | -$1.22 | -1.19 | $33,333 | |
| 03/29/2021 | Q4 2020 | -$0.03 | -$1.59 | -1.56 | $62,500 | |
| 11/06/2020 | Q3 2020 | -$0.03 | -$1.44 | -1.41 | $24,536 | $95,833 |
| 08/10/2020 | Q2 2020 | -$0.03 | -$1.42 | -1.39 | $24,491 | $0 |
| 05/11/2020 | Q1 2020 | -$0.03 | -$1.32 | -1.29 | $0 | |
| 03/09/2020 | Q4 2019 | -$0.03 | -$1.71 | -1.68 | $-89,812 |
Matinas BioPharma Holdings, Inc. Earnings: Frequently Asked Questions
-
When is Matinas BioPharma Holdings, Inc.'s earnings date?
Matinas BioPharma Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based off last year's report dates.
-
How can I listen to Matinas BioPharma Holdings, Inc.'s earnings conference call?
The conference call for Matinas BioPharma Holdings, Inc.'s latest earnings report can be listened to online.
-
How can I read Matinas BioPharma Holdings, Inc.'s conference call transcript?
The conference call transcript for Matinas BioPharma Holdings, Inc.'s latest earnings report can be read online.
-
How much revenue does Matinas BioPharma Holdings, Inc. generate each year?
Matinas BioPharma Holdings, Inc. (:MTNB) has a recorded annual revenue of $1.10 M.
-
How much profit does Matinas BioPharma Holdings, Inc. generate each year?
Matinas BioPharma Holdings, Inc. (:MTNB) has a recorded net income of $1.10 M. Matinas BioPharma Holdings, Inc. has generated $-5.28 earnings per share over the last four quarters.
-
What is Matinas BioPharma Holdings, Inc.'s price-to-earnings ratio?
Matinas BioPharma Holdings, Inc. (:MTNB) has a price-to-earnings ratio of -0.15 and price/earnings-to-growth ratio is -0.01.
